The role of oxidative stress and inflammation biomarkers in pre- and postoperative monitoring of prostate cancer patients

References

• Krieghoff-Henning E, Folkerts J, Penzkofer A, et al. Cancer – an overview. Med Monatsschr Pharm. 2017;40(2):48–54.
   PubMedGoogle Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Patel AR, Klein EA. Risk factors for prostate cancer. Nat Clin Pract Urol. 2009;6(2):87–95. doi: 10.1038/ncpuro1290.
   PubMedGoogle Scholar
• Cuzick J, Thorat MA, Andriole G, et al. Prevention and early detection of prostate cancer. Lancet Oncol. 2014;15(11):e484–e492. doi: 10.1016/S1470-2045(14)70211-6.
   PubMed Web of Science ®Google Scholar
• Rao AR, Motiwala HG, Karim OMA. The discovery of prostate-specific antigen. BJU Int. 2007;101(1):5–10. doi: 10.1111/j.1464-410X.2007.07138.x.
   PubMed Web of Science ®Google Scholar
• Nguyen-Nielsen M, Borre M. Diagnostic and therapeutic strategies for prostate cancer. Semin Nucl Med. 2016;46(6):484–490. doi: 10.1053/j.semnuclmed.2016.07.002.
   PubMed Web of Science ®Google Scholar
• Litwin MS, Tan H-J. The diagnosis and treatment of prostate cancer. JAMA. 2017;317(24):2532–2542. doi: 10.1001/jama.2017.7248.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Allsbrook WC, Amin MB, et al. The 2005 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29(9):1228–1242. doi: 10.1097/01.pas.0000173646.99337.b1.
   PubMed Web of Science ®Google Scholar
• Pizzino G, Irrera N, Cucinotta M, et al. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev. 2017;2017:8416763. vol doi: 10.1155/2017/8416763.
   PubMed Web of Science ®Google Scholar
• Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204–7218. doi: 10.18632/oncotarget.23208.
   PubMedGoogle Scholar
• Mahal BA, Gerke T, Awasthi S, et al. Prostate cancer racial disparities: a systematic review by the prostate cancer foundation panel. Eur Urol Oncol. 2022;5(1):18–29. doi: 10.1016/j.euo.2021.07.006.
   PubMed Web of Science ®Google Scholar
• Miller DR. “The Role of ROS in the Progression and Treatment of Castration-Resistant Prostate Cancer.” https://digitalcommons.unmc.edu/etd/352, 2019. Accessed: Nov. 04, 2022.
   Google Scholar
• Minciullo PL, Inferrera A, Navarra M, et al. Oxidative stress in benign prostatic hyperplasia: a systematic review. Urol Int. 2015;94(3):249–254. doi: 10.1159/000366210.
   PubMed Web of Science ®Google Scholar
• Tan BL, Norhaizan ME, Liew W-P-P. Nutrients and oxidative stress: friend or foe? Oxid Med Cell Longev. 2018; 2018: 9719584. doi: 10.1155/2018/9719584.
   PubMedGoogle Scholar
• Ahmed Amar SA, Eryilmaz R, Demir H, et al. Determination of oxidative stress levels and some antioxidant enzyme activities in prostate cancer. Aging Male. 2019;22(3):198–206. doi: 10.1080/13685538.2018.1488955.
   PubMed Web of Science ®Google Scholar
• Battisti V, Maders LDK, Bagatini MD, et al. Oxidative stress and antioxidant status in prostate cancer patients: relation to gleason score, treatment and bone metastasis. Biomed Pharmacother. 2011;65(7):516–524. doi: 10.1016/j.biopha.2011.06.003.
   PubMed Web of Science ®Google Scholar
• Oh B, Figtree G, Costa D, et al. Oxidative stress in prostate cancer patients: a systematic review of case control studies. Prostate Int. 2016;4(3):71–87. doi: 10.1016/j.prnil.2016.05.002.
   PubMed Web of Science ®Google Scholar
• Ghiselli A, Serafini M, Natella F, et al. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med. 2000;29(11):1106–1114. doi: 10.1016/S0891-5849(00)00394-4.
   PubMed Web of Science ®Google Scholar
• Ham H-J, Park J-W, Bae Y-S. Defect of SIRT1-FoxO3a axis is associated with the production of reactive oxygen species during protein kinase CK2 downregulation-mediated cellular senescence and nematode aging. BMB Rep. 2019;52(4):265–270. doi: 10.5483/BMBRep.2019.52.4.156.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. doi: 10.1038/nature01322.
   PubMed Web of Science ®Google Scholar
• Moreira DM, Nickel JC, Andriole GL, et al. Chronic baseline prostate inflammation is associated with lower tumor volume in men with prostate cancer on repeat biopsy: results from the REDUCE study. Prostate. 2015;75(13):1492–1498. doi: 10.1002/pros.23041.
   PubMed Web of Science ®Google Scholar
• Holliday EB, Dieckmann NF, McDonald TL, et al. Relationship between fatigue, sleep quality and inflammatory cytokines during external beam radiation therapy for prostate cancer: a prospective study. Radiother Oncol. 2016;118(1):105–111. doi: 10.1016/j.radonc.2015.12.015.
   PubMed Web of Science ®Google Scholar
• Salazar N, Castellan M, Shirodkar SS, et al. Chemokines and chemokine receptors as promoters of prostate cancer growth and progression. Crit Rev Eukaryot Gene Expr. 2013;23(1):77–91. doi: 10.1615/CritRevEukaryotGeneExpr.2013006905.
   PubMed Web of Science ®Google Scholar
• Dwivedi S, Goel A, Natu SM, et al. Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: a prospective study. Asian Pac J Cancer Prev. 2011;12(7):1843–1848.
   PubMedGoogle Scholar
• Funahashi Y, Majima T, Matsukawa Y, et al. Intraprostatic reflux of urine induces inflammation in a rat. Prostate. 2017;77(2):164–172. doi: 10.1002/pros.23257.
   PubMed Web of Science ®Google Scholar
• Partin AW, Carter HB, Chan DW, et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol. 1990;143(4):747–752. doi: 10.1016/S0022-5347(17)40079-6.
   PubMed Web of Science ®Google Scholar
• Yli-Hemminki TH, Laurila M, Auvinen A, et al. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the finnish prostate cancer screening trial. BJU Int. 2013;112(6):735–741. doi: 10.1111/bju.12153.
   PubMed Web of Science ®Google Scholar
• Yun BH, Hwang EC, Yu HS, et al. Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy? Int Urol Nephrol. 2015;47(8):1251–1257. doi: 10.1007/s11255-015-1029-6.
   PubMed Web of Science ®Google Scholar
• Velissaris D, Zareifopoulos N, Karamouzos V, et al. Presepsin as a diagnostic and prognostic biomarker in sepsis. Cureus. 2021;13(5):e15019. doi: 10.7759/cureus.15019.
   PubMed Web of Science ®Google Scholar
• Hamdy FC, Donovan JL, Lane JA, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–1424. doi: 10.1056/NEJMoa1606220.
   PubMed Web of Science ®Google Scholar